The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ib/II study of fruquintinib in combination with SOX and toripalimab as first-line treatment for advanced metastatic gastric/gastroesophageal junction adenocarcinoma (GC/GEJC).
 
Xiangrui Meng
No Relationships to Disclose
 
Zhengzheng Shan
No Relationships to Disclose
 
Lulu Guan
No Relationships to Disclose
 
Xin Dao
No Relationships to Disclose
 
Qingxia Fan
No Relationships to Disclose
 
Feng Wang
No Relationships to Disclose